> 数据图表如何才能3.1 创新药(H）：收入稳定增长，持续经营利润扭亏后快速提升2025-9-13.1 创新药(H）：收入稳定增长，持续经营利润扭亏后快速提升图表24：H股创新药公司经营数据代码3692.HK1801.HK9926.HK6990.HK1530.HK1548.HK2096.HK0867.HK6855.HK9688.HK1952.HK0013.HK2162.HK2616.HK2186.HK2171.HK2142.HK2315.HK9966.HK6955.HK2105.HK1167.HK6996.HK2487.HK6978.HK6998.HK2126.HK2137.HK0950.HK9939.HK2257.HK简称翰森制药信达生物康方生物-B科伦博泰生物-B三生制药金斯瑞生物科技先声药业康哲药业亚盛医药-B再鼎医药云顶新耀-B和黄医药康诺亚-B基石药业-B绿叶制药科济药业和铂医药-B百奥赛图康宁杰瑞制药-B博安生物来凯医药-B加科思-B德琪医药-B科笛-B永泰生物-B嘉和生物-B药明巨诺腾盛博药-B李氏大药厂开拓药业-B圣诺医药-B资料来源：Wind、中邮证券研究所请参阅附注免责声明市值（亿元）2,181.11,658.81,397.61,059.1709.2375.1349.4319.1309.2286.3223.0206.7206.6157.6140.0133.1124.790.490.286.466.764.243.337.127.122.519.713.610.710.49.7202421.3%51.8%-53.3%25.5%16.2%-29.4%-0.1%-6.8%335.7%49.6%317.5%-24.8%20.0%-13.5%-1.5%#DIV/0!-57.5%36.8%192.6%17.4%#DIV/0!145.1%36.5%101.0%-100.0%#DIV/0!-9.1%-100.0%27.7%829.4%1714.3%营业收入增速2025H114.3%45.6%32.6%-29.0%-1.1%-7.7%14.9%7.3%-71.7%15.4%47.8%-9.2%808.0%-80.8%2.9%703.8%327.5%51.3%84.0%-1.4%#DIV/0!511.7%-12.5%-31.2%820.6%74.3%22.1%#DIV/0!2.4%119580.0%-82.8%2025H115.0%312.5%-138.9%-146.8%24.6%85.4%32.2%3.4%-462.4%33.0%60.5%1671.2%76.6%-1821.0%AtYvg2gB8xMJKfqJsSndK/xNPvPAOe91Q8WlcrcbfOXlGwXz3i+/bx6EAA7Ole+U持续经营利润增速202433.4%90.8%-125.4%53.5%34.9%28.6%2.6%-32.5%56.2%22.0%-23.3%-62.0%-43.4%75.2%-11.4%-6.7%-87.6%108.8%179.0%161.3%31.1%56.6%45.1%77.9%44.2%92.4%23.1%-190.7%469.7%85.4%33.7%-19.3%78.5%4958.8%194.7%148.1%-66.7%9.8%100.0%54.3%-19.1%-39.5%100.0%-11.2%47.2%7.4%-16.5%91.0%2025归母净利润一致预期（亿元）PE（2025E）48.46.4-1.9-5.260.31.211.216.5-9.5-1.6-4.13.9-6.7-2.56.6-4.90.91.5-3.51.1-3.1-2.3-2.5-3.50.00.00.00.00.00.00.041.1238.0-659.2-184.510.739.628.417.6-29.6-23.6-49.56.8-28.3-58.619.4-24.717.356.8-23.271.6-19.5-25.7-15.5-9.60.00.00.00.00.00.00.019中邮证券健康医疗
